1. AMPYRA (dalfampridine)
Dalfampridine, marketed under the name Ampyra by Acorda Therapeutics in the United States (also referred to as Fampyra in Europe), is an FDA-approved drug that is used to improve walking in patients with multiple sclerosis (MS). Owing to its chemical properties and its role in the regulation of potassium channels on cell membranes, it is also used as a research tool in therapeutics dealing with several unmet medical conditions, as well as a convulsant to test for anti-seizure agents.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?